Curex is an online telehealth weight-management service that provides personalized access to prescription GLP-1 treatment through licensed U.S. healthcare providers. Eligible patients can receive compounded semaglutide or tirzepatide in injectable or oral dissolving tablet formats, along with medication delivery and ongoing care-team support.
Curex is an online telehealth service focused on prescription weight management. Instead of requiring patients to visit a traditional weight-loss clinic, its process is completed online. Patients provide information about their health history, goals, medications, and other relevant factors before a licensed provider reviews the information.
If treatment is considered appropriate, the provider can create a personalized plan and prescribe a GLP-1 medication. Curex currently lists compounded semaglutide and tirzepatide, with both injection and oral dissolving tablet options available through its program.
This distinction is important: Curex itself is the healthcare platform and care service, while semaglutide and tirzepatide are prescription medications that may be included in an individual's treatment plan.
The process is designed to be completed remotely in three primary stages.
1. Complete the Medical Intake
The first step involves an online questionnaire covering information such as medical history, current medications, weight-management goals, and other health details. Curex says the intake takes approximately two minutes and can be completed without an office visit.
Providing accurate information matters because prescription treatment should be based on an individual's health circumstances rather than simply choosing a medication based on price or popularity.
2. Licensed Provider Review
A licensed U.S. provider reviews the submitted information. Curex says providers review the intake within 24 hours and determine whether treatment is appropriate. Depending on location and medical history, consultation may take place through video or asynchronous text communication.
If medication is prescribed, the provider determines the appropriate treatment and dosage based on the individual's circumstances.
3. Medication Delivery and Ongoing Care
After approval and prescription, medication is shipped through a licensed U.S. compounding pharmacy. Curex states that medication generally ships within one to two days and that free shipping is included with its plans.
Patients also receive ongoing access to the care team for questions, refills, dose adjustments, and treatment-related support.
GLP-1 refers to glucagon-like peptide-1, a hormone involved in regulating appetite, blood sugar, and other metabolic processes. GLP-1-based medications can influence appetite and satiety, which can make it easier for some people to reduce food intake and maintain a calorie deficit.
Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both GIP and GLP-1 pathways. Clinical research has demonstrated substantial weight-loss effects with these medications in appropriate patients.
For example, a 2025 randomized trial published in the New England Journal of Medicine compared tirzepatide and semaglutide in adults with obesity without type 2 diabetes. At 72 weeks, average weight reduction was greater with tirzepatide than semaglutide in that study. However, clinical-trial results should not be interpreted as a guarantee of what an individual Curex patient will experience.
The program is designed around remote healthcare. Patients can complete the initial process online rather than scheduling a traditional clinic appointment.
Curex states that prescriptions are written by licensed U.S. physicians or nurse practitioners after reviewing a patient's medical history.
Patients may potentially have access to semaglutide or tirzepatide in injectable or oral dissolving formats, depending on provider assessment and availability.
The program includes online access to the care team for treatment questions, dose adjustments, side-effect support, and refill-related concerns.
Curex states that insurance is not required and that FSA and HSA cards are accepted.
Curex offers a 365-day money-back guarantee designed to provide additional confidence when starting a personalized weight-management program. Eligible customers who follow their prescribed treatment plan and do not experience weight loss may qualify for a full refund, subject to the applicable guarantee requirements.
Customers who complete the medical evaluation but are not prescribed treatment may also qualify for a full refund under the program terms.
The guarantee is subject to specific eligibility conditions, so customers should review the applicable terms before enrolling.
For eligible patients, prescription GLP-1 treatment can offer several potential advantages compared with relying exclusively on lifestyle changes.
The medications may help reduce appetite and food cravings, potentially making it easier to maintain reduced calorie intake. Research also supports meaningful average weight loss with GLP-1-based therapies in appropriate populations.
Another potential advantage is structured medical oversight. Rather than obtaining medication without professional guidance, Curex connects patients with licensed providers who review their health information.
The convenience of online consultations and home delivery can also remove some logistical barriers associated with traditional weight-management clinics.
Still, convenience does not eliminate the need for appropriate medical supervision.
Curex states that the oral dissolving tablets are intended for people who prefer a needle-free option. The provider determines which treatment, if any, is appropriate rather than allowing patients to select a prescription independently.
GLP-1 medications have been extensively studied for weight management. Their effects are not based simply on a marketing concept; randomized clinical trials have demonstrated meaningful reductions in body weight among appropriately selected patients.
The SURMOUNT-5 trial, published in 2025, directly compared tirzepatide with semaglutide in adults with obesity who did not have diabetes. At 72 weeks, participants receiving tirzepatide experienced a greater average reduction in body weight than participants receiving semaglutide. Gastrointestinal adverse events were among the most common side effects in both groups, particularly during dose escalation.
However, these findings relate to the studied medications and trial populations. They should not be used to predict an individual's exact outcome.
Traditional weight management often begins with nutrition, physical activity, behavioral changes, sleep, and other lifestyle interventions. These remain important components of healthy weight management.
Prescription GLP-1 treatment takes a different approach by adding medication that influences physiological pathways involved in appetite and metabolism.
Curex combines prescription treatment with remote medical care. The main difference is therefore not that one approach completely replaces another. For many patients, medication and sustainable lifestyle habits may need to work together.
Curex may be worth exploring for adults who are considering prescription-based weight management and want to complete the evaluation process online.
However, being interested in GLP-1 treatment does not automatically mean someone qualifies. Curex states that prescriptions depend on a provider's assessment of the patient's health information.
Medical history, current medications, existing conditions, potential contraindications, and other factors can influence whether treatment is appropriate.
The current Curex promotional page lists introductory pricing starting at $49 for the first month for semaglutide and $149 for the first month for tirzepatide. It also states that plans include medication, free shipping, and ongoing care.
The page also lists standard pricing from $199 per month and states that there are no membership fees. Because promotional pricing can change, prospective customers should verify the current price and terms before enrolling.
Curex says no insurance is required and that FSA/HSA cards are accepted.
Curex states that its providers may prescribe compounded semaglutide or tirzepatide when medically appropriate. A prescription requires provider review.
No. Curex states that it does not offer or supply Ozempic, Wegovy, Mounjaro, or Zepbound. Its current program focuses on compounded semaglutide and tirzepatide.
No. Curex states that insurance is not required and that FSA and HSA cards are accepted.
Curex states that prescribed medication generally ships within one to two days from a licensed U.S. compounding pharmacy, with free shipping included.
No. Curex explicitly states that its compounded medications are not FDA-approved for safety or effectiveness.
Curex states that it is available in all 50 states, although California currently has restrictions that limit prescriptions through this program to oral tablet formulations.
Explore personalized GLP-1 weight loss care with clinician-guided support, convenient online consultations, and treatment options tailored to your individual needs.